Sunday, May 27, 2012

Clinically proven herbs?

Kalyana Mitta, Wisdom Quarterly
What is Protandim?
Protandim, to the best of our knowledge, is the only supplement in the world clinically proven (in a peer-reviewed, human clinical study) to reduce aging factors by an average of 40 percent. 
  
Protandim has been granted four patents and is at present the subject of more than 20 independent clinical studies.
  
This patented antioxidant therapy is many times more powerful than red wine, oranges, blueberries, juices, or other popular supplements. 
  
Protandim works by increasing the body’s natural antioxidant protection at the cellular level, triggering cells to produce naturally occurring protective antioxidant enzymes such as superoxide dismutase (SOD), catalase, and the enzymes involved in glutathione synthesis and metabolism.

"Food should be our medicine; medicine should be our food."
- Hippocrates
Eat more whole, green, unprocessed foods.
Drink filtered water.
Breathe deeply.
Smile.
  
Is Protandim a Nrf2 Activator?
Protandim’s actions result from its ability to activate the transcription factor known as Nrf2.
  
Protandim contains five ingredients that are known to scientists as Nrf2 activators:
  1. turmeric (curcumin)
  2. ashwagandha (Indian winter cherry)
  3. bacopa (brahmi)
  4. milk thistle (everything interacts)
  5. green tea (leaf)
  • QUESTION: How hard would it be to make a smoothie? Combine powder form of each (from bulk and supplement sections of any good health food store) in equal parts. Thank the plants for working their synergistic magic. Take a teaspoon or two as food with purified water, juice, or almond milk.
Nrf2 is a protein messenger contained in every cell of the body that sends information to the cell’s DNA. That DNA consists of about 25,000 genes and the products of those genes make us who and what we are [physically]. They are unique for each person. DNA is what makes us human beings, what gives us [the physical manifestations of] our personality, what gives us our physical traits. More

No comments: